Liver Cancer
Conditions
Interventions
Sponsors
Beijing Ditan Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria for hepatocellular carcinoma; (2) Chronic hepatitis B virus infection; (3) Patients with BCLC stage C and D; (4) Men or women aged 18-65 years; (5) TCM syndrome differentiation of deficiency of qi and yin, accumulation of poison stasis; (6) Signing of informed consent.
Exclusion criteria
Exclusion criteria: (1) Those who have a history of allergies to the applied Chinese medicine components; (2) Overlapping hepatitis A, E or C and other hepatitis virus infections; (3) Combining autoimmune hepatitis, drug-induced hepatitis, alcoholic liver disease, and various genetic metabolic liver diseases; (4) Tuberculosis infection; (5) HIV-infected patients; (6) Patients with severe heart and kidney complications or other primary diseases; (7) Patients with liver cancer metastasized from other tumors or patients with malignant tumors in other locations; (8) Upper gastrointestinal bleeding; (9) Hepatorenal syndrome; (10) Pregnant or lactating women; (11) People with mental illness who cannot cooperate; patients with a history of epilepsy and central nervous system disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall Survival of 48 weeks; | — |
Secondary
| Measure | Time frame |
|---|---|
| Medium survival time;Solid tumor remission rate;AFP level;Liver function;Child-Pugh class;Complication rate;TCM Syndrome Points; | — |
Countries
China
Contacts
Public ContactXianbo Wang
Beijing Ditan Hospital, Capital Medical University
Outcome results
None listed